Skip to Main Content

Paper Details

Treatment of retinitis pigmentosa due to MERTK mutations by ocular subretinal injection of adeno-associated virus gene vector: results of a phase I trial.
Hum Genet
166
2016
Author NameAffiliation
Huimin CaiInstitute for Genomic Medicine, University of California San Diego
Huimin CaiChengdu JiaChuan Biomedicine Co.
Huimin CaiGuangzhou KangRui Biological Pharmaceutical Technology Company Ltd.
Rui HouChengdu JiaChuan Biomedicine Co.
Rui HouGuangzhou KangRui Biological Pharmaceutical Technology Company Ltd.
David G BirchRetina Foundation of the Southwest
Kang ZhangInstitute for Genomic Medicine, University of California San Diego
Kang ZhangVeterans Administration Healthcare System
Fowzan S AlkurayaKing Faisal Specialist Hospital and Research Center
Fowzan S AlkurayaCollege of Medicine, Alfaisal University
  • 1 - 10

Datasets